Walvax Biotechnology Company (SHE: 300142)

Walvax Biotechnology Company is a corporation based in Kunming, China. Established in 2001, the company is a biological pharmaceutical enterprise engaged in research and development, production, and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenzae type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines. The assets are managed by the executive team.